top
Search terms
Results 1 - 2 of 2 - ordered by :
Ehjournal

Abstract Aims X-VeRT is the first prospective randomized trial of a novel oral anticoagulant in patients with atrial fibrillation undergoing elective cardioversion. Methods and results We assigned ...

European Heart Journal, ESC Hot Line Barcelona, Riccardo Cappato, Michael D. Ezekowitz, Allan L. Klein, A. John Camm, Chang-Sheng Ma, Jean-Yves Le Heuzey, Mario Talajic, Maurício Scanavacca, Panos ...

Date : 14/12/2014
Epeuropace

Experimental studies demonstrated that AF-induced electrical and structural remodelling of the fibrillating atria perpetuate AF (AF begets AF Furthermore, there is growing understanding that the ...

Europace, NOVEL NONPHARMACOLOGICAL THERAPIES FOR AF, Julia Koebe, Paulus Kirchhof

Date : 01/04/2008